Evidence map›Paper›PMID 42180433›Full record

ArticleMolecular vision2025

Targeted sequencing with single-molecule molecular inversion probes highlights a gap in understanding the cause of Fuchs endothelial corneal dystrophy.

Bushra Alayed, Danah Albuainain, Salina Siddiqui, Weijia Li, Ummey Hany, Seema Anand, Chris F Inglehearn, Christopher M Watson, Manir Ali

Abstract read
In one paragraph

Article in Molecular vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bushra AlayedDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Danah AlbuainainDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Salina SiddiquiDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Weijia LiDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Ummey HanyDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Seema AnandThe Eye Department, St. James's University Hospital, Leeds, UK.
Chris F InglehearnDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Christopher M WatsonDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.
Manir AliDivision of Molecular Medicine, Leeds Institute of Medical Research, St. James's University Hospital, University of Leeds, Leeds, UK.

Funding

MRC Clinical Research Training Fellowship G1002002/1
6 · The paper itself

Abstract

Purpose: A trinucleotide repeat expansion in Methods: Genomic DNA from blood was genotyped for expansion of the CTG18.1 repeat in intron 2 of Results: Analysis of 114 FECD cases by STR/TP-PCR stratified the patients into FECD expansion-negative cases that had <50 trinucleotide repeats on both alleles at the CTG18.1 locus (n = 33 probands and three additional family members) and FECD expansion-positive (n = 78) cases with at least one allele harboring ≥50 repeats in size. All 36 expansion negative cases were then analyzed by smMIP targeted capture and short-read sequencing of the five other genes implicated in FECD causation. For comparison, two control groups were similarly analyzed: a subset of 29 of the expansion-positive cases whose FECD was assumed to be caused by the repeat expansion and 29 expansion-negative unaffected individuals. Across all groups, 13 variants passed filtration criteria: 1 in Conclusions: smMIPs were used for targeted screening of candidate genes implicated in FECD and proved a versatile, economic approach for prescreening before whole-exome or genome sequencing. This study confirmed the well-documented enrichment of the

Indexed as

Fuchs' Endothelial DystrophyMolecular ProbesTrinucleotide Repeat ExpansionAgedAnion Transport ProteinsAntiportersBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCarrier ProteinsCollagen Type VIIIExonsFemaleGenotypeHumansMaleMiddle AgedReceptors, Cell SurfaceAnion Transport ProteinsAntiportersBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCarrier ProteinsCOL8A2 protein, humanCollagen Type VIIILOXHD1 protein, humanMolecular ProbesReceptors, Cell SurfaceSLC4A11 protein, humanTCF4 protein, humanTranscription Factor 4Transcription FactorsZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID42180433
PMCPMC13193275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.